enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. List of antineoplastic agents - Wikipedia

   en.wikipedia.org/wiki/List_of_antineoplastic_agents

   Metastatic small cell lung cancer. Hepatotoxicity [17] Mechlorethamine: IV, intra pleural, intra pericardial, topical Alkylates DNA. Hodgkin disease, chronic leukimia, lung cancer, polycythemia vera, T-cell lymphoma, mycosia fungoides Hepatotoxicity (rare) [18] Melphalan: IV, PO: Alkylates DNA.

3. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

4. Targeted therapy of lung cancer - Wikipedia

   en.wikipedia.org/.../Targeted_therapy_of_lung_cancer

   Lung cancer is an extremely heterogeneous family of malignant neoplasms, [1] with well over 50 different histological variants recognized under the 4th revision of the World Health Organization (WHO) typing system, currently the most widely used lung cancer classification scheme. [2]

5. WHO keeps key lung cancer drugs off its essential medicines list

   www.aol.com/news/updates-essential-medicines...

   GENEVA/ZURICH (Reuters) - The world's master list of recommended medicines got an update on Tuesday when the World Health Organization (WHO) published a biennial revision, adding 28 drugs ...

6. US FDA approves Amgen drug for small cell lung cancer - AOL

   www.aol.com/news/us-fda-approves-amgen-drug...

   The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...

7. ALK inhibitor - Wikipedia

   en.wikipedia.org/wiki/ALK_inhibitor

   ALK inhibitors are anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation. [1] They fall under the category of tyrosine kinase inhibitors , which work by inhibiting proteins involved in the abnormal growth of tumour cells.